Webcast - Randomized Phase II Conference Call
Date & Time: Tuesday, June 5, 2012 - 9:00 AM ET
Oncolytics Biotech Inc.
About Oncolytics Biotech Inc.
Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN(R), its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.
Available in archive via Podcast.